John E. Kao (ALHC) reports multiple 10b5-1 stock sales through March 2026
Rhea-AI Filing Summary
ALHC reported Form 144 sales by or for John E. Kao under 10b5-1 plans. The excerpt lists multiple reported dispositions of Common stock, including sales of $1,133,514.66 across transactions on 12/29/2025 and repeated sales of $3,273,558.00 and similar amounts in early 2026. The filings show routine plan-based sales rather than corporate actions.
Positive
- None.
Negative
- None.
Insights
Reported sales are executed under pre-arranged 10b5-1 plans and represent routine dispositions.
The excerpt lists multiple Common stock sales attributed to John E. Kao and the JEK Trust U/A DTD 02/08/2021, including transactions on 01/12/2026 and 03/10/2026. Several entries explicitly cite a 10b5-1 Sales Plan, indicating pre‑arranged trading.
Cash flow recipients and aggregate remaining holdings are not disclosed in the excerpt; subsequent SEC filings would show settlement/stock‑count effects. The transactions are factual disclosures of dispositions, not company operational developments.
FAQ
What did ALHC insiders report in the Form 144?
Were the sales by John E. Kao part of a 10b5-1 plan?
How large were the reported transactions in the Form 144?
Does Form 144 disclose who receives the sale proceeds?
Do these Form 144 entries change ALHC corporate governance or operations?